Longbow Finance’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-47,266
Closed -$4.51M 60
2025
Q4
$4.51M Sell
47,266
-74,595
-61% -$7.31M 0.76% 51
2025
Q3
$11.9M Buy
121,861
+59,829
+96% +$6.2M 1.17% 24
2025
Q2
$6.66M Hold
62,032
0.71% 58
2025
Q1
$6.26M Buy
+62,032
New +$6.25M 0.75% 43

Other funds holding BSX

Longbow Finance's BSX Position: Q1 2026 in Review

Longbow Finance sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 47,266 shares — an estimated $4.51M sold.

Longbow Finance first reported a position in BSX in Q1 2025 and held it in 4 quarters. The position peaked at $11.9M in Q3 2025. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Longbow Finance reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Longbow Finance sold 47,266 Boston Scientific shares in Q1 2026, an estimated $4.51M.
  • Longbow Finance first reported a position in Boston Scientific in Q1 2025 and held it in 4 quarters.
  • Longbow Finance's Boston Scientific position peaked at $11.9M in Q3 2025.
  • 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Longbow Finance's 13F filing for Q1 2026, filed 12 May 2026.